Ray Dalio's TECH Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 5,977 shares of Bio-Techne Corporation (TECH) worth $312,358, representing 0.00% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in TECH, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2015, adding 51,912 shares. Largest reduction occurred in Q1 2019, reducing 49,068 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +5,977 | New Buy | 5,977 | $52.26 |
| Q4 2025 | -41,146 | Sold Out | 0 | $0.00 |
| Q3 2025 | +41,146 | New Buy | 41,146 | $55.63 |
| Q2 2024 | -4,082 | Sold Out | 0 | $0.00 |
| Q1 2024 | -3,220 | Reduce 44.10% | 4,082 | $70.39 |
| Q4 2023 | -5,016 | Reduce 40.72% | 7,302 | $77.16 |
| Q3 2023 | +331 | Add 2.76% | 12,318 | $68.07 |
| Q2 2023 | -40,999 | Reduce 77.38% | 11,987 | $81.63 |
| Q1 2023 | +47,341 | Add 838.64% | 52,986 | $74.19 |
| Q4 2022 | -10,203 | Reduce 64.38% | 5,645 | $82.88 |
| Q3 2022 | -2,876 | Reduce 15.36% | 15,848 | $70.99 |
| Q2 2022 | +4,352 | Add 30.28% | 18,724 | $86.68 |
| Q1 2022 | +10,244 | Add 248.16% | 14,372 | $108.27 |
| Q4 2021 | +288 | Add 7.50% | 4,128 | $129.36 |
| Q3 2021 | +3,840 | New Buy | 3,840 | $121.09 |
| Q4 2019 | -8,440 | Sold Out | 0 | $0.00 |
| Q3 2019 | +8,440 | New Buy | 8,440 | $48.93 |
| Q1 2019 | -49,068 | Sold Out | 0 | $0.00 |
| Q4 2018 | +41,336 | Add 534.61% | 49,068 | $36.17 |
| Q3 2018 | -22,812 | Reduce 74.69% | 7,732 | $51.09 |
| Q2 2018 | -3,724 | Reduce 10.87% | 30,544 | $37.00 |
| Q1 2018 | +34,268 | New Buy | 34,268 | $37.76 |
| Q4 2017 | -7,820 | Sold Out | 0 | $0.00 |
| Q3 2017 | -11,692 | Reduce 59.92% | 7,820 | $30.18 |
| Q2 2017 | +19,512 | New Buy | 19,512 | $29.37 |
| Q1 2016 | -9,912 | Sold Out | 0 | $0.00 |
| Q4 2015 | -42,000 | Reduce 80.91% | 9,912 | $22.50 |
| Q3 2015 | +51,912 | New Buy | 51,912 | $23.12 |
| Q2 2015 | -17,128 | Sold Out | 0 | $0.00 |
| Q1 2015 | +1,200 | Add 7.53% | 17,128 | $25.05 |
| Q4 2014 | +15,928 | New Buy | 15,928 | $23.10 |
Ray Dalio's Bio-Techne Corporation Investment FAQs
Ray Dalio first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 15,928 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Bio-Techne Corporation (TECH) for 31 quarters since Q4 2014.
Ray Dalio's largest addition to Bio-Techne Corporation (TECH) was in Q3 2015, adding 51,912 shares worth $1.2 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 5,977 shares of Bio-Techne Corporation (TECH), valued at approximately $312,358.
As of the Q1 2026 filing, Bio-Techne Corporation (TECH) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Bio-Techne Corporation (TECH) was 52,986 shares, as reported at the end of Q1 2023.